Liu TL - Search Results

1

Evaluation of a novel monoclonal antibody mAb109 by immuno-PET/fluorescent imaging for noninvasive lung adenocarcinoma diagnosis.

Zhu H, Liu TL, Liu CH, Wang J, Zhang H, Dong B, Shen J, Zhao CK, Li ZF, Cheng Z, Yang Z. Zhu H, et al. Among authors: liu ch, liu tl. Acta Pharmacol Sin. 2020 Jan;41(1):101-109. doi: 10.1038/s41401-019-0294-9. Epub 2019 Sep 18. Acta Pharmacol Sin. 2020. PMID: 31534200 Free PMC article.

2

⁶⁸Ga/¹⁷⁷Lu-labeled DOTA-TATE shows similar imaging and biodistribution in neuroendocrine tumor model.

Liu F, Zhu H, Yu J, Han X, Xie Q, Liu T, Xia C, Li N, Yang Z. Liu F, et al. Tumour Biol. 2017 Jun;39(6):1010428317705519. doi: 10.1177/1010428317705519. Tumour Biol. 2017. PMID: 28618966 Free article.

3

⁶⁴Cu-PSMA-617: A novel PSMA-targeted radio-tracer for PET imaging in gastric adenocarcinoma xenografted mice model.

Han XD, Liu C, Liu F, Xie QH, Liu TL, Guo XY, Xu XX, Yang X, Zhu H, Yang Z. Han XD, et al. Among authors: liu c, liu tl, liu f. Oncotarget. 2017 May 26;8(43):74159-74169. doi: 10.18632/oncotarget.18276. eCollection 2017 Sep 26. Oncotarget. 2017. PMID: 29088775 Free PMC article.

4

Design, Synthesis, and Biological Evaluation of ⁶⁸Ga-DOTA-PA1 for Lung Cancer: A Novel PET Tracer for Multiple Somatostatin Receptor Imaging.

Liu F, Liu T, Xu X, Guo X, Li N, Xiong C, Li C, Zhu H, Yang Z. Liu F, et al. Mol Pharm. 2018 Feb 5;15(2):619-628. doi: 10.1021/acs.molpharmaceut.7b00963. Epub 2018 Jan 19. Mol Pharm. 2018. PMID: 29278911

5

⁶⁸Ga-PSMA-617 PET/CT: a promising new technique for predicting risk stratification and metastatic risk of prostate cancer patients.

Liu C, Liu T, Zhang N, Liu Y, Li N, Du P, Yang Y, Liu M, Gong K, Yang X, Zhu H, Yan K, Yang Z. Liu C, et al. Eur J Nucl Med Mol Imaging. 2018 Oct;45(11):1852-1861. doi: 10.1007/s00259-018-4037-9. Epub 2018 May 2. Eur J Nucl Med Mol Imaging. 2018. PMID: 29717333

6

Noninvasive Detection of HER2 Expression in Gastric Cancer by ⁶⁴Cu-NOTA-Trastuzumab in PDX Mouse Model and in Patients.

Guo X, Zhu H, Zhou N, Chen Z, Liu T, Liu F, Xu X, Jin H, Shen L, Gao J, Yang Z. Guo X, et al. Mol Pharm. 2018 Nov 5;15(11):5174-5182. doi: 10.1021/acs.molpharmaceut.8b00673. Epub 2018 Oct 9. Mol Pharm. 2018. PMID: 30251865

7

Synthesis and preclinical evaluation of ⁶⁸Ga-PSMA-BCH for prostate cancer imaging.

Liu T, Liu C, Liu F, Xu X, Guo X, Xia L, Zhu H, Yang Z. Liu T, et al. Bioorg Med Chem Lett. 2019 Apr 1;29(7):933-937. doi: 10.1016/j.bmcl.2019.01.013. Epub 2019 Jan 17. Bioorg Med Chem Lett. 2019. PMID: 30745258

8

(2S,4R)-4-[¹⁸F]Fluoroglutamine as a PET Indicator for Bone Marrow Metabolism Dysfunctional: from Animal Experiments to Clinical Application.

Zhu H, Liu F, Zhang Y, Yang J, Xu X, Guo X, Liu T, Li N, Zhu L, Kung HF, Yang Z. Zhu H, et al. Mol Imaging Biol. 2019 Oct;21(5):945-953. doi: 10.1007/s11307-019-01319-4. Mol Imaging Biol. 2019. PMID: 30793240

9

Preclinical Evaluation and Pilot Clinical Study of Al¹⁸F-PSMA-BCH for Prostate Cancer PET Imaging.

Liu T, Liu C, Xu X, Liu F, Guo X, Li N, Wang X, Yang J, Yang X, Zhu H, Yang Z. Liu T, et al. J Nucl Med. 2019 Sep;60(9):1284-1292. doi: 10.2967/jnumed.118.221671. Epub 2019 Feb 22. J Nucl Med. 2019. PMID: 30796170 Free article.

10

Targeting CAIX with [⁶⁴Cu]XYIMSR-06 Small Molecular Radiotracer Enables Noninvasive PET Imaging of Malignant Glioma in U87 MG Tumor Cell Xenograft Mice.

Yang X, Zhu H, Yang X, Li N, Huang H, Liu T, Guo X, Xu X, Xia L, Deng C, Tian X, Yang Z. Yang X, et al. Mol Pharm. 2019 Apr 1;16(4):1532-1540. doi: 10.1021/acs.molpharmaceut.8b01210. Epub 2019 Mar 12. Mol Pharm. 2019. PMID: 30803240

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

434 results

Search Page

Filters